Okay, thank you.
Dr. Beaudet, on December 7 you kindly came to the neurological subcommittee and we talked about the importance of follow-up care. We're still hearing stories that people are having difficulty getting follow-up care. You kindly said that you would do what you could to ensure it's occurring.
Could you table with the committee what actions you have taken to ensure follow-up care for MS patients who receive CCSVI treatment overseas?